(Health-NewsWire.Net, January 28, 2016 ) Myelodysplastic syndrome is a group of hematologic disorders that arise in the bone marrow and spread into the blood. The syndrome is characterized by the inability of the hematopoietic cells produced in the bone marrow to attain maturity. Cytological dysplasia is a common feature of the syndrome, progressing to acute myeloid leukemia in about 30% of individuals with myelodysplastic syndrome. The disease is age-related, mostly affecting people aged 60 and above. Smoking, exposure to radiation, contact with chemicals such as benzene, genetic mutations, and chemotherapy can cause myelodysplastic syndrome.
Technavios analysts forecast the global myelodysplastic syndrome market to grow at a CAGR of 9.93% during the period 2015-2019.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=527262
Covered in this report The report covers the present scenario and the growth prospects of the global myelodysplastic syndrome market for 2015-2019. To calculate the market size, we consider revenue generated from the sales of various drugs used for treating myelodysplastic syndrome. The report describes the market by region: Americas: The US, Canada, Mexico, and Brazil EMEA: The UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE APAC: Japan, China, Australia, Singapore, South Korea, and India
Technavio's report, Global Myelodysplastic Syndrome Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors Celgene Novartis Otsuka
Other prominent vendors Acceleron Pharma Amgen Astellas Astex Actinium Pharmaceuticals Bellicum Pharmaceuticals BioLineRx Celator Pharmaceuticals Cornerstone Pharmaceuticals CTI BioPharma Eli Lilly Gamida Cell GlaxoSmithKline KaloBios Pharmaceuticals Kiadis Pharma Mirati Therapeutics Onconova Therapeutics Strategia Therapeutics Sumitomo Dainippon Pharma Sunesis Pharmaceuticals Targazyme TetraLogic Pharmaceuticals
Market driver Rise in aging population For a full, detailed list, view our report
Market challenge Use of off-label drugs For a full, detailed list, view our report
Market trend Rise in public awareness For a full, detailed list, view our report
Key questions answered in this report What will the market size be in 2019 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
Browse Detail Report With TOC @ http://www.researchmoz.us/global-myelodysplastic-syndrome-market-2015-2019-report.html
Table Of Content
PART 01: Executive summary Highlights PART 02: Scope of the report Market overview Top-vendor offerings PART 03: Product profile REVLIMID VIDAZA Dacogen Glivec/Gleevec PART 04: Market research methodology Research methodology Economic indicators PART 05: Introduction Key market highlights PART 06: Disease overview Understanding the disease Risk factors Signs and symptoms Pathophysiology Types Diagnosis Epidemiology Treatment PART 07: Pipeline portfolio Information on pipeline candidates PART 08: Market landscape Market overview Market size and forecast Five forces analysis PART 09: Market segmentation by drug class Alkylating agents Cytotoxic antibiotics Topoisomerase inhibitors Others PART 10: Market segmentation by route of administration Oral Parenteral PART 11: Geographical Segmentation Myelodysplastic syndrome market in EMEA Myelodysplastic syndrome market in APAC PART 12: Market drivers Rise in aging population Unmet medical needs Use of diagnostic tools PART 13: Impact of drivers PART 14: Market challenges Use of off-label drugs Adverse effects of drugs High cost of drugs PART 15: Impact of drivers and challenges
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=527262
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz Mr. Nachiket Ghumare, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/
Browse Our Latest Press Releases @ http://www.researchmoz.us/pressrelease
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com
|